Brainfarma Industria Química e Farmacêutica S/A   Report issue

For profit Phase 3
Founded: Anapolis Brazil (1959)
Status: No NME R&D (1959)

Organization Overview

First Clinical Trial
2016
NCT02735070
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Brainfarma Industria Química e Farmacêutica S/A

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Common Cold (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 7